Skip to main content
. 2022 Jul 28;10(8):1813. doi: 10.3390/biomedicines10081813

Figure 1.

Figure 1

Flow-chart summarizing the main tools for the estimation of recurrence risk/metastatic potential and therefore, for defining the personalized follow-up of PPGL patients.